心脏病学和心血管医学中的大数据时代：用于真正个性化医疗的高级分析。
The Big Data Era in Cardiology and Cardiovascular Medicine: Advanced Analytics for Truly Personalized Care.
作者信息
Ambrosino Pasquale, Manzo Fabio, Candia Claudio, Spedicato Giorgio Alfredo, Grassi Guido, Maniscalco Mauro
机构信息
Istituti Clinici Scientifici Maugeri IRCCS, Scientific Directorate of Telese Terme Institute, 82037 Telese Terme, Italy.
Fleming Clinical Laboratory, 81020 Casapulla, Italy.
出版信息
Diagnostics (Basel). 2025 Jul 3;15(13):1705. doi: 10.3390/diagnostics15131705.
Abstract
In recent years, a growing body of alarming epidemiological evidence has suggested that cardiovascular diseases (CVDs) are the leading cause of disability and premature mortality worldwide [...].
摘要
近年来，越来越多令人担忧的流行病学证据表明，心血管疾病（CVDs）是全球致残和过早死亡的主要原因[……]。
相似文献
1
The Big Data Era in Cardiology and Cardiovascular Medicine: Advanced Analytics for Truly Personalized Care.心脏病学和心血管医学中的大数据时代：用于真正个性化医疗的高级分析。
Diagnostics (Basel). 2025 Jul 3;15(13):1705. doi: 10.3390/diagnostics15131705.
2
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
4
Mediterranean Diet for Primary and Secondary Prevention of Cardiovascular Disease and Mortality: An Updated Systematic Review.地中海饮食对心血管疾病和死亡率的一级和二级预防作用：一项更新的系统性综述。
Nutrients. 2023 Jul 28;15(15):3356. doi: 10.3390/nu15153356.
5
SIRT3 as a potential biomarker and therapeutic target for cardiovascular diseases: a meta-analysis of clinical studies.SIRT3作为心血管疾病的潜在生物标志物和治疗靶点：临床研究的荟萃分析
Future Cardiol. 2025 Aug;21(10):779-788. doi: 10.1080/14796678.2025.2527535. Epub 2025 Jul 4.
6
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.手机短信用于心血管疾病二级预防中的药物依从性。
Cochrane Database Syst Rev. 2024 Mar 27;3(3):CD011851. doi: 10.1002/14651858.CD011851.pub3.
7
All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.自闭症患者的全因死亡率及特定死因：一项全国性分析。
Autism Adulthood. 2025 Feb 5;7(1):81-92. doi: 10.1089/aut.2023.0103. eCollection 2025 Feb.
8
Burden of cardiovascular disease attributed to air pollution: a systematic review.归因于空气污染的心血管疾病负担：系统评价。
Global Health. 2024 May 3;20(1):37. doi: 10.1186/s12992-024-01040-0.
9
Big data for neuroscience in the context of predictive, preventive, and personalized medicine.预测性、预防性和个性化医学背景下的神经科学大数据。
EPMA J. 2024 Dec 23;16(1):17-35. doi: 10.1007/s13167-024-00393-1. eCollection 2025 Mar.
10
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
本文引用的文献
1
Raising the Alarm: Underdiagnosis of Cardiac Sarcoidosis in Young Patients With Unexplained Heart Block.敲响警钟：不明原因心脏传导阻滞的年轻患者中心肌结节病的诊断不足
JACC Adv. 2025 Jun 20;4(7):101890. doi: 10.1016/j.jacadv.2025.101890.
2
Clinical effectiveness of tirzepatide for patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study.替尔泊肽治疗心房颤动合并2型糖尿病患者的临床疗效：一项回顾性队列研究。
Diabetes Res Clin Pract. 2025 Jul;225:112279. doi: 10.1016/j.diabres.2025.112279. Epub 2025 May 22.
3
Association of herpes zoster vaccination and cardiovascular risk in patients with diabetes: long-term insights from a retrospective cohort study.糖尿病患者中带状疱疹疫苗接种与心血管风险的关联：一项回顾性队列研究的长期见解
BMJ Open. 2025 Feb 18;15(2):e090428. doi: 10.1136/bmjopen-2024-090428.
4
Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists to Dipeptidyl Peptidase 4 Inhibitors in Patients With Heart Failure and Type 2 Diabetes.心力衰竭合并2型糖尿病患者中胰高血糖素样肽-1受体激动剂与二肽基肽酶4抑制剂的比较结局
J Am Heart Assoc. 2025 Feb 18;14(4):e037510. doi: 10.1161/JAHA.124.037510. Epub 2025 Feb 8.
5
Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?精准医学与心血管预防及人群健康：难以跨越的桥梁？
Circulation. 2024 Nov 19;150(21):1720-1731. doi: 10.1161/CIRCULATIONAHA.124.070081. Epub 2024 Nov 18.
6
Global burden of cardiovascular diseases: projections from 2025 to 2050.心血管疾病的全球负担：2025年至2050年的预测
Eur J Prev Cardiol. 2024 Sep 13. doi: 10.1093/eurjpc/zwae281.
7
Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database.利用全球联邦数据库进行真实世界分析：常规心脏生物标志物预测肾小球肾炎患者主要不良心脏事件的发生。
BMC Nephrol. 2024 Jul 22;25(1):233. doi: 10.1186/s12882-024-03667-y.
8
Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias.多模态可解释人工智能识别出患有非缺血性心肌病且有致命性室性心律失常风险的患者。
Sci Rep. 2024 Jun 27;14(1):14889. doi: 10.1038/s41598-024-65357-x.
9
Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review.人工智能引领心血管照护变革：从发现到实践：JACC 前沿观点述评。
J Am Coll Cardiol. 2024 Jul 2;84(1):97-114. doi: 10.1016/j.jacc.2024.05.003.
10
Revolutionizing Cardiology through Artificial Intelligence-Big Data from Proactive Prevention to Precise Diagnostics and Cutting-Edge Treatment-A Comprehensive Review of the Past 5 Years.通过人工智能革新心脏病学——从主动预防到精准诊断与前沿治疗的大数据——过去五年的全面综述
Diagnostics (Basel). 2024 May 26;14(11):1103. doi: 10.3390/diagnostics14111103.
Zotero 插件